FCPM III SERVICES B.V. Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$762.9B
Holdings
10
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (10 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NAMSNEWAMSTERDAM PHARMA COMPANY | 9,198,900 | $322.7B | 42.30% | |
| 2 | DYNDYNE THERAPEUTICS INC | 5,462,846 | $106.9B | 14.01% | |
| 3 | ENGNENGENE HOLDINGS INC | 9,632,561 | $87.0B | 11.40% | |
| 4 | RAPTRAPT THERAPEUTICS INC | 1,833,333 | $62.1B | 8.14% | |
| 5 | MPLTMAPLIGHT THERAPEUTICS INC | 3,226,400 | $56.7B | 7.43% | |
| 6 | VORVOR BIOPHARMA INC | 3,617,354 | $47.3B | 6.20% | |
| 7 | REPLREPLIMUNE GROUP INC | 2,808,368 | $27.3B | 3.58% | |
| 8 | BCYCBICYCLE THERAPEUTICS PLC | 3,468,430 | $24.6B | 3.22% | |
| 9 | CBIOCRESCENT BIOPHARMA INC. | 1,677,852 | $19.9B | 2.61% | |
| 10 | ENGNWENGENE HOLDINGS INC | 2,878,148 | $8.5B | 1.12% |